http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeaf27d6806c3293d422e569b58ffaf2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Salih |
| name | Helmut R Salih Helmut R. Salih |
| given-name | Helmut R. Helmut R |
| organization-name | Sergio Amadori and Adriano Venditti, Tor Vergata University Hospital; Paolo De Fabritiis, St Eugenio Hospital; Roberto Latagliata, University Sapienza; Paola Fazi and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell'Adulto, Roma; Franca Falzetti, University Hospital, Perugia; Domenico Magro, Pugliese Hospital, Catanzaro; Giorgina Specchia, University Hospital, Bari, Italy; Stefan Suciu and Matthias Karrasch, European Organisation for Research and Treatment of Cancer, Brussels; Dominik Selleslag... Universitätsklinikum Tübingen, Tübingen, Germany; and German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tübingen, Germany Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany *Department of Hematology and Jan Krönke, Richard F. Schlenk, Kai-Ole Jensen, Florian Tschürtz, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Shiva Onken, Karina Eiwen, Marianne Habdank, Daniela Späth, Hartmut Döhner, and Konstanze Döhner, University Hospital of Ulm, Ulm; Michael Lübbert, University of Freiburg Medical Center, Freiburg; Mohammed Wattad, Evangelic Hospital Essen-Werden, Essen; Thomas Kindler, University Medical Center, Johannes Gutenberg University, Mainz; Helmut R. Salih, Eberhard Karls University, Tübingen;... Department of Internal MedicineCenter of Clinical Transfusion MedicineEberhard Karls-UniversityTübingenGermany Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany Authors' Affiliations: 1Department of Gastroenterology and Hepatology, Medical University Hospital; 2Interfaculty Institute for Biochemistry, University of Tuebingen; 3Department of Hematology and Oncology, Eberhard Karls University; Departments of 4General, Visceral, and Transplant Surgery, and 5Pathology, University Hospital Tuebingen, Tuebingen; 6German Cancer Consortium (DKTK) and German Cancer Research Center, Heidelberg; 7University Children's Hospital, Ulm University, Ulm; and 8Institute for Experimental Cancer Research in Pediatrics, Goethe University Frankfurt, Frankfurt, Germany; and 9Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia Universitätsklinikum Tübingen, Tübingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine University Hospital Tübingen Tübingen Germany Abteilung II fuer Onkologie, Haematologie, Immunologie, Rheumatologie, und Pulmologie, Medizinische Universitaetsklinik, Otfried Mueller Straße 10, 72076 Tuebingen, Germany German Consortium for Translational Cancer Research, Heidelberg, Germany;; Department of Hematology and Oncology, Eberhard Karls University, Tübingen, Germany; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany;; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium, German Cancer Research Center (DKFZ) partner site Tübingen, Germany; From the Albert Ludwigs University, Freiburg; University of Dresden, Dresden; St Johannes-Hospital, Duisburg, Duisburg; Heinrich-Heine-University, Düsseldorf; University Hospital Tübingen, Tübingen; University of Hannover, Hannover; Diakoniekrankenhaus Bremen, Bremen, Germany; European Organisation for Research and Treatment of Cancer Headquarters, Brussels; AZ St Jan, Brugge; University of Leuven, Leuven, Belgium; University Hospital Zagreb, Zagreb, Croatia; Radboud University Nijmegen Medical Center,... University Hospital Tuebingen, Department for Oncology, Hematology, Immunology, Rheumatology and Pulmonology, Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tuebingen, Germany Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany. *Department of Internal Medicine II, University Hospital and Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany; Department of Hematology and Oncology, University of Tuebingen, Tuebingen; and Department of Hematology and Oncology, Medical Department 2, University Hospital of Tuebingen, Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, Department for Internal Medicine II, German Cancer Consortium and German Cancer Research Center, Partner site Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany;; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium, German Cancer Research Center Partner Site Tübingen, Tübingen, Germany; Department of Hematology/Oncology, University of Tuebingen Medical Center II, Tuebingen; Department of Hematology and Oncology, University of Tübingen, Tübingen 72076, Germany;; Clinical Cooperation Unit Translational Immunology, DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen 72076, Germany; and Department of Internal Medicine II, University Hospital, Eberhard-Karls-University, Tübingen, Germany; Department of Hematology/Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany Uwe Platzbecker, Christian Thiede, Christoph Röllig, and Gerhard Ehninger, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden; Uwe Platzbecker and Gerhard Ehninger, Study Alliance Leukemia, Dresden; Walter Fiedler, University Hospital Hamburg-Eppendorf; Norbert Schmitz, Asklepios Klinik St Georg Hamburg, Hamburg; Peter Brossart, Innere Medizin mit deSchwerpunkten Onkologie, Haematollogie un Rheumatologie, Bonn; Bernd Hertenstein, Klinikum Bremen Mitte, Bremen; Helmut R. Salih,... 2Department of Hematology and Oncology, Medical University Hospital; *Immunology, Inflammation, and Pulmonary, and 2Internal Medicine II, and *Department of Immunology, Inflammation, and Pulmonary Diseases, Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, NJ 08540; and †University Medical Hospital, Department of Hematology/Oncology, University of Tübingen, Tübingen, Germany Clinical Cooperation Unit Translational Immunology, German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany; and *Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany;; †Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany; Abteilung II fuer Onkologie, Haematologie, Immunologie, Rheumatologie, und Pulmologie, Medizinische Universitaetsklinik, D-72076 Tuebingen, Germany;; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, Partner site Tuebingen, D-72076 Tuebingen, Germany |
Incoming Links
Total number of triples: 136.